Champions Oncology, Inc. (CSBR)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Champions Oncology, Inc.’s names, not what it holds today.
1 published
1 published
1 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Sep 29, 2009 | 7,595,326 | Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs | Pharmaceuticals | Champions Biotechnology, Inc |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 23, 2018 | 2018/0237861 | PERSONALIZED TREATMENT OF DISEASES AND DISORDERS | Pharmaceuticals | CHAMPIONS ONCOLOGY, INC. |
| Jun 7, 2018 | 2018/0153145 | HUMANIZED MICE AND USES THEREOF | Other special machines | Champions Oncology, Inc. |
| May 4, 2017 | 2017/0118965 | HUMANIZED MOUSE MODELS AND USES THEREOF | Pharmaceuticals | Champions Biotechnology, Inc |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.